CBO Scores $2.5 Billion Deficit Reduction From Multiple Drug Pricing Bills

By John Wilkerson / June 7, 2022 at 3:35 PM
The Congressional Budget Office estimated the budget impact of three Senate drug pricing bills to reform antitrust and patent enforcement laws that combined would reduce the deficit by $1.9 billion over a decade. CBO also estimates House FDA user fee legislation would cut the deficit by $598 million with measures that speed generic competition; the House is set to vote on the bill this week. The savings from the four bills combined are minuscule compared to the more than $100...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.